Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial
January 2020
in “Journal of The American Academy of Dermatology”
TLDR Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.
This study compared the effectiveness of low-dose oral minoxidil (OM) and topical minoxidil (TM) 5% solution for the treatment of female pattern hair loss (FPHL). The results showed that low dose OM provides improvement of FPHL that does not differ from TM 5% solution, with a safe profile and well-tolerated adverse effects. OM can be considered an option for FPHL patients with poor compliance and/or intolerability of TM.
View this study on jaad.org →
Cited in this study
research Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C’s of oral therapy
Oral minoxidil helps hair growth, is cost-effective, and mostly well-tolerated.
research Translation into Portuguese language (Brazil), transcultural adaptation and validation of the quality of life questionnaire in female pattern hair loss (WAA-QoL-BP)
Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.
research Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone
Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.
research Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study
Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.
research Hair shedding in women: how much is too much?
The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.
Related
research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil
A study explored the treatment of Sisaipho alopecia areata, a rare variant of AA characterized by hair loss on the top of the scalp while sparing the temporal and occipital areas, using tofacitinib and oral minoxidil. The combination of these treatments showed promise in managing this challenging condition, which typically presents as nonscarring hair loss and can be difficult to treat.
research A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss
Patients generally have positive attitudes towards using topical Minoxidil for hair loss treatment.
research Comprehensive Review of Oral Minoxidil in Alopecia
research Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
Using minoxidil and tofacitinib together can effectively treat severe hair loss.
research The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss
research Off-Label Use of Topical Minoxidil in Alopecia: A Review
Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.
research The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review
Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.
research Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment
Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.